NO923642L - USE OF 5-TRANS-PROSTAGLANDIN F2ALFA AS AN OCULAR HYPOTENSIVE AGENT - Google Patents

USE OF 5-TRANS-PROSTAGLANDIN F2ALFA AS AN OCULAR HYPOTENSIVE AGENT

Info

Publication number
NO923642L
NO923642L NO92923642A NO923642A NO923642L NO 923642 L NO923642 L NO 923642L NO 92923642 A NO92923642 A NO 92923642A NO 923642 A NO923642 A NO 923642A NO 923642 L NO923642 L NO 923642L
Authority
NO
Norway
Prior art keywords
trans
prostaglandin
f2alfa
hypotensive agent
ocular hypotensive
Prior art date
Application number
NO92923642A
Other languages
Norwegian (no)
Other versions
NO923642D0 (en
Inventor
David Frederick Woodward
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1991/000986 external-priority patent/WO1991014428A1/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO923642L publication Critical patent/NO923642L/en
Publication of NO923642D0 publication Critical patent/NO923642D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrorer et middel for å redusere eller opprettholde intraokulart trykk, og spesielt en fremgangsmåte og blanding for å redusere eller opprettholde intraokulært trykk som medfører administrering av en blanding innholdende 5-trans prostaglandin Fza i en farmasøytisk akseptabel bærer.The invention relates to a means for reducing or maintaining intraocular pressure, and in particular to a method and composition for reducing or maintaining intraocular pressure which results in administration of a composition containing 5-trans prostaglandin Fza in a pharmaceutically acceptable carrier.

NO923642A 1990-03-19 1992-09-18 USE OF 5-TRANS-PROSTAGLANDIN F2ALFA AS AN OCULAR HYPOTENSIVE AGENT NO923642D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49687990A 1990-03-19 1990-03-19
PCT/US1991/000986 WO1991014428A1 (en) 1990-03-19 1991-02-12 USE OF 5-TRANS PROSTAGLANDIN F2α AS AN OCULAR HYPOTENSIVE AGENT

Publications (2)

Publication Number Publication Date
NO923642L true NO923642L (en) 1992-09-18
NO923642D0 NO923642D0 (en) 1992-09-18

Family

ID=26782949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923642A NO923642D0 (en) 1990-03-19 1992-09-18 USE OF 5-TRANS-PROSTAGLANDIN F2ALFA AS AN OCULAR HYPOTENSIVE AGENT

Country Status (2)

Country Link
AU (1) AU644422B2 (en)
NO (1) NO923642D0 (en)

Also Published As

Publication number Publication date
AU7442191A (en) 1991-10-21
AU644422B2 (en) 1993-12-09
NO923642D0 (en) 1992-09-18

Similar Documents

Publication Publication Date Title
EP1224934A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
DK0527801T3 (en) Thiophene sulfonamides useful as carbohydrate inhibitors
ES2042625T5 (en) USE OF A PROSTAGLANDINE IN COMBINATION WITH AN ADRENERGIC BLOCKING AGENT FOR THE REDUCTION OF INTRAOCULAR PRESSURE.
LU92058I2 (en) Travoprost and its pharmaceutically acceptable salts (TRAVATAN®)
NO924873D0 (en) PROCEDURE FOR THE PREPARATION OF HYALURONIC ACID AND FRACTIONATION OF PURE HYALURONIC ACID FOR Ophthalmological Use
DE69521620D1 (en) USE OF 9-DEOXYPROSTAGLAND IN DERIVATIVES FOR TREATING GLAUCOMA
ES2053458T3 (en) USE OF PROSTAGLANDINS A, B AND C AND DERIVATIVES THEREOF, FOR THE TREATMENT OF EYE HYPERTENSION AND GLAUCOMA.
SE8703854D0 (en) PROSTAGLAND INGREDIENTS FOR TREATMENT OF GLAUCOME OR OCULAR HYPERTENSION
TW427913B (en) Eye drop composition comprising pilocarpine and a β-blocking agent and process making the same
ES2079872T3 (en) EYE HYPOTENSIVE DERIVATIVES OF 2-DESCARBOXIL-2-ACILTIOALQUILPROSTAGLANDINA.
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
NO980058L (en) Ophthalmic preparations
MY120578A (en) Method for treating glaucoma
NO923642L (en) USE OF 5-TRANS-PROSTAGLANDIN F2ALFA AS AN OCULAR HYPOTENSIVE AGENT
NO923546L (en) USE OF PROSTAGLANDIN F3ALFA AS AN OCULAR HYPOTENSIVE AGENT
DK0861250T3 (en) Amindine and isothiourea derivatives as inhibitors of nitrogen monoxide synthase
DE69119900D1 (en) Use of prostaglandin F3alpha as an ocular hypotensive
DE69829062D1 (en) USE OF FLUNARIZIN FOR TOPICAL TREATMENT OF OCULAR HIGH PRESSURE
EP0302757A3 (en) Anti-emetic serotonin depleting agents
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
WO1992010473A3 (en) 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
EP0122178A3 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
EP1300151A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU625096C (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension